448 related articles for article (PubMed ID: 26731268)
21. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome.
Lin W; Wen L; Wen J; Xiang G
Front Endocrinol (Lausanne); 2021; 12():747888. PubMed ID: 34858330
[TBL] [Abstract][Full Text] [Related]
22. Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole.
Li Y; Zhu Y; Li D; Liu W; Zhang Y; Liu W; Zhang C; Tao T
Front Endocrinol (Lausanne); 2023; 14():1265152. PubMed ID: 37929036
[TBL] [Abstract][Full Text] [Related]
23. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age.
Maliqueo M; Sun M; Johansson J; Benrick A; Labrie F; Svensson H; Lönn M; Duleba AJ; Stener-Victorin E
Endocrinology; 2013 Jan; 154(1):434-45. PubMed ID: 23183180
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiome Composition in Polycystic Ovary Syndrome Adult Women: A Systematic Review and Meta-analysis of Observational Studies.
Zhu Q; Zhang N
Reprod Sci; 2024 Jul; 31(7):1800-1818. PubMed ID: 38212581
[TBL] [Abstract][Full Text] [Related]
25. Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.
Skarra DV; Hernández-Carretero A; Rivera AJ; Anvar AR; Thackray VG
Endocrinology; 2017 Sep; 158(9):2988-3003. PubMed ID: 28911175
[TBL] [Abstract][Full Text] [Related]
26. Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies.
Babu A; Devi Rajeswari V; Ganesh V; Das S; Dhanasekaran S; Usha Rani G; Ramanathan G
Reprod Sci; 2024 Jun; 31(6):1508-1520. PubMed ID: 38228976
[TBL] [Abstract][Full Text] [Related]
27. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
28. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
29. Temporal relationship between alterations in the gut microbiome and the development of polycystic ovary syndrome-like phenotypes in prenatally androgenized female mice.
Kusamoto A; Harada M; Azhary JMK; Kunitomi C; Nose E; Koike H; Xu Z; Urata Y; Kaku T; Takahashi N; Wada-Hiraike O; Hirota Y; Koga K; Fujii T; Osuga Y
FASEB J; 2021 Nov; 35(11):e21971. PubMed ID: 34653284
[TBL] [Abstract][Full Text] [Related]
30. Intestinal Flora is a Key Factor in Insulin Resistance and Contributes to the Development of Polycystic Ovary Syndrome.
Yang YL; Zhou WW; Wu S; Tang WL; Wang ZW; Zhou ZY; Li ZW; Huang QF; He Y; Zhou HW
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34145455
[TBL] [Abstract][Full Text] [Related]
31. Sodium oligomannate's amelioration of reproductive and metabolic phenotypes in a letrozole-induced PCOS-like mouse model depends on the gut microbiome.
Li Z; Liu Y; Wang Y; Cai Q; Wang Y; Bai Y; Liu H; Xu C; Zhang F
Biol Reprod; 2024 Mar; ():. PubMed ID: 38630889
[TBL] [Abstract][Full Text] [Related]
32. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome.
Chu W; Han Q; Xu J; Wang J; Sun Y; Li W; Chen ZJ; Du Y
Fertil Steril; 2020 Jun; 113(6):1286-1298.e4. PubMed ID: 32482258
[TBL] [Abstract][Full Text] [Related]
33. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
Xue J; Li X; Liu P; Li K; Sha L; Yang X; Zhu L; Wang Z; Dong Y; Zhang L; Lei H; Zhang X; Dong X; Wang H
Endocr J; 2019 Oct; 66(10):859-870. PubMed ID: 31270279
[TBL] [Abstract][Full Text] [Related]
34. Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota.
Prakash A; Nourianpour M; Senok A; Atiomo W
Cells; 2022 Sep; 11(19):. PubMed ID: 36231000
[TBL] [Abstract][Full Text] [Related]
35. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.
Han Q; Wang J; Li W; Chen ZJ; Du Y
Microbiome; 2021 May; 9(1):101. PubMed ID: 33957990
[TBL] [Abstract][Full Text] [Related]
36. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population.
Mammadova G; Ozkul C; Yilmaz Isikhan S; Acikgoz A; Yildiz BO
Eur J Clin Invest; 2021 Apr; 51(4):e13417. PubMed ID: 32991745
[TBL] [Abstract][Full Text] [Related]
37. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype.
Wang L; Zhou J; Gober HJ; Leung WT; Huang Z; Pan X; Li C; Zhang N; Wang L
Biomed Pharmacother; 2021 Jan; 133():110958. PubMed ID: 33171400
[TBL] [Abstract][Full Text] [Related]
38. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis.
Sherman SB; Sarsour N; Salehi M; Schroering A; Mell B; Joe B; Hill JW
Gut Microbes; 2018; 9(5):400-421. PubMed ID: 29469650
[TBL] [Abstract][Full Text] [Related]
39. The role of nesfatin-1 expression in letrozole-induced polycystic ovaries in the rat.
Xu Y; Zhang H; Li Q; Lao K; Wang Y
Gynecol Endocrinol; 2017 Jun; 33(6):438-441. PubMed ID: 28277136
[TBL] [Abstract][Full Text] [Related]
40. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
